Legislation


HB 1689 – Washington

Status: Enacted
Year Introduced: 2022
Link: https://app.leg.wa.gov/billsummary?BillNumber=1689&Year=2021&Initiative=false

Requires health plans to exempt biomarker testing for cancer or cancer progression or recurrence from prior authorization requirements.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found